Advisor

Suneel Singh

• Ph.D., MBA

Dr. Singh has over 17 years of post-PhD experience in the academic and pharma/biotech industry in both scientific and business roles. Over the last decade, his primary focus has been to support C(R)DMOs effort to gain market access in the Americas and Europe. During his career, he led and/or supported sales efforts for several CDMOs, eg, IDT Biologika, Dr Reddy’s/Aurigene Pharmaceutical Services Ltd, Biocon, Biovectra/Mallinckrodt, Kudo Bio. Dr. Singh is a CDMO business expert on a variety of technologies for manufacturing drug substances and drug products, including small molecules, biologics from microbial and mammalian processes, viral vectors, viral vaccines, mRNA, and cell and gene therapies. He has worked with small and large pharma/biotech companies to provide development and manufacturing services for both clinical and commercial programs.

Prior to transitioning to business roles in the pharma and biotech industry, Dr. Singh left his mark in academic research, where he conducted and published research of high impact in synthetic organic chemistry from the University of Guelph, ON and Queen’s University, ON, Canada. Dr. Singh holds a Doctorate in Chemistry from the Indian Institute of Technology New Delhi, India and received his MBA from Cornell and Queen’s Universities.